Comparison of Bupivacaine–Magnesium Sulphate versus RopivacaineMagnesium Sulphate for Surgical Site Infiltration in Lumbar Spine Surgery: A Prospective Randomized Double-Blind Study
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.213 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Bhagy Shree Ganoliya und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Lumbar spine surgeries often result in significant postoperative pain, and achieving effective analgesia is essential for early mobilization and enhanced recovery. Local anesthetic wound infiltration is a simple and effective component of multimodal analgesia. This study compares the analgesic efficacy of bupivacaine–magnesium sulphate versus ropivacaine–magnesium sulphate for surgical site infiltration in lumbar spine surgery.
Methods
This prospective, randomized, double-blind study included 70 ASA I–II patients aged 25–60 years undergoing elective lumbar spine surgery. Patients were allocated to two groups (n=35 each). Group A received 70 mg bupivacaine with 500 mg magnesium sulphate diluted to 20 mL; Group B received 70 mg ropivacaine with 500 mg magnesium sulphate diluted to 20 mL. The study evaluated postoperative pain using the Visual Analog Scale (VAS) at extubation, 6, 12, and 24 hours; time to first rescue analgesia; total diclofenac consumption within 24 hours; hemodynamic parameters; and adverse effects.
Results
Demographic variables were comparable between groups. VAS scores at 6, 12, and 24 hours were significantly lower in Group B (p < 0.05). The time to first rescue analgesia was significantly longer in Group B (8.49 ± 4.11 h) compared with Group A (5.51 ± 3.21 h; p = 0.0012). Total diclofenac consumption was also significantly lower in Group B (128.57 ± 71.77 mg) than in Group A (188.57 ± 61.34 mg; p = 0.0004). Hemodynamic stability and adverse event profiles were similar in both groups.
Conclusion
Ropivacaine combined with magnesium sulphate provides superior postoperative analgesia compared with bupivacaine–magnesium sulphate in lumbar spine surgery. It prolongs analgesia duration, lowers pain scores, and reduces rescue analgesic requirements while maintaining a comparable safety profile. Ropivacaine–magnesium infiltration may be preferred as part of multimodal analgesia protocols in lumbar spine procedures.
Zitieren
APA
Ganoliya, B. S., Sharma, N., Bagri, P., & Gupta, D. (2026). Comparison of Bupivacaine–Magnesium Sulphate versus RopivacaineMagnesium Sulphate for Surgical Site Infiltration in Lumbar Spine Surgery: A Prospective Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.213
Vancouver
Ganoliya BS, Sharma N, Bagri P, Gupta D. Comparison of Bupivacaine–Magnesium Sulphate versus RopivacaineMagnesium Sulphate for Surgical Site Infiltration in Lumbar Spine Surgery: A Prospective Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.213
BibTeX
@article{Ganoliya2026,
author = {Ganoliya, Bhagy Shree and Sharma, Neelu and Bagri, Pradeep and Gupta, Dilip},
title = {Comparison of Bupivacaine–Magnesium Sulphate versus RopivacaineMagnesium Sulphate for Surgical Site Infiltration in Lumbar Spine Surgery: A Prospective Randomized Double-Blind Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.213}
}
EUVIMED